Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medtronic plc Director's Dealing 2020

Nov 10, 2020

29841_dirs_2020-11-10_b5b863a2-1999-409d-95db-1f1664ccff82.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2020-11-09

Reporting Person: Lerman Bradley E (SVP General Counsel & Corp Sec)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-11-09 Ordinary Shares M 19918 $62.76 Acquired 74066 Direct
2020-11-09 Ordinary Shares M 797 $62.76 Acquired 74863 Direct
2020-11-09 Ordinary Shares S 20715 $113.13 Disposed 54148 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-11-09 Stock Option (Right to Buy) $62.76 M 19918 Disposed 2024-07-28 Ordinary Shares (19918) Direct
2020-11-09 Stock Option (Right to Buy) $62.76 M 797 Disposed 2024-07-28 Ordinary Shares (797) Direct

Footnotes

F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2: This option became exercisable on June 29, 2018, upon achievement of a pre-specified cash Earnings Per Share Growth Rate for fiscal years 2016 through 2018.